JOPIC
Journal of Pulmonology and Intensive Care

The JoPIC is an independent-unbiased, peer-reviewed, and open-access journal of current national and international issues and reviews for original clinical and experimental research, interesting case reports, surgical techniques, differential diagnoses, editorial opinions, letters to the editor, and educational papers in pulmonology, thoracic surgery, occupational diseases, allergology, and intensive care medicine.

eISSN: 2980-0803
Creative Commons CC BY-NC-ND 4.0 International License.
EndNote Style

Online Manuscript System

Index
Original Article
The relationship between serum C-reactive protein to albumin ratio and the severity and prognosis of COVID-19
Abstract
Aims: During the Coronavirus Disease 2019 (COVID-19) pandemic, early identification of especially severe and critical cases may improve prognosis. In this context, laboratory parameters play an important role. This study investigated the relationship between the serum C-reactive protein (CRP)/albumin ratio (CAR) and disease prognosis in patients with COVID-19.
Methods: This study included patients who were hospitalized with a possible or confirmed diagnosis of COVID-19 at the Chest Diseases Clinic of the University of Health Sciences Dışkapı Yıldırım Beyazıt Training and Research Hospital Health Practice and Research Center between March 1, 2020, and March 31, 2021. Data on the patients were retrospectively reviewed using the hospital’s record system. A total of 444 patients were included in the study and divided into two groups: those with a diagnosis of severe disease (n=141) and those without (n=303). The serum CAR was compared between the two groups. In addition, the relationship between CAR and demographic, clinical, and laboratory findings was evaluated.
Results: The mean CAR in the group with severe disease was found to be 36.1, while it was 17.1 in the group without severe disease, and the difference was statistically significant (p<0.001). ROC analyses showed that CAR had higher area under the curve (AUC) values compared to CRP alone in predicting severe disease, the development of complications, need for respiratory support or intensive care, and mortality. The optimal threshold values identified for CAR were as follows: 26.06 for predicting severe disease (sensitivity 66%, specificity 64%), 26.04 for complications (sensitivity 61%, specificity 62%), 26.06 for intensive care need (sensitivity 63%, specificity 62%), 25.21 for need for respiratory support (sensitivity 60%, specificity 60%), and 27.2 for mortality (sensitivity 62%, specificity 59%). These findings demonstrate that an increased CAR level is significantly associated with poor prognosis in COVID-19 patients. The Relationship Between Serum C-Reactive Protein to Albumin Ratio and the Severity of COVID-19
Conclusion: The data obtained indicate that the CRP to albumin ratio (CAR) is a potential biomarker for predicting severe disease and poor prognosis in COVID-19 patients. Therefore, integrating CAR into the clinical evaluation process may contribute to the early identification of high-risk patients and the timely implementation of appropriate treatment approaches.

Keywords : SARS-CoV-2, CAO, C-reactive protein, albumin

Download Article


1. Ranzani OT, Zampieri FG, Forte DN, Azevedo LCP, Park M. C-reactive protein/albumin ratio predicts 90-day mortality of septic patients. PLoS One. 2013;8(3):e59321. doi:10.1371/journal.pone.0059321
2. Kaplan M, Ates I, Akpinar MY, et al. Predictive value of C-reactive protein/albumin ratio in acute pancreatitis. Hepatobiliary Pancreat Dis Int. 2017;16(4):424-430. doi:10.1016/S1499-3872(17)60007-9
3. Zhou T, Zhan J, Hong S, et al. Ratio of C-reactive protein/albumin is an inflammatory prognostic score for predicting overall survival of patients with small-cell lung cancer. Sci Rep. 2015;5:10481. doi:10.1038/srep10481
4. Koh YW, Lee HW. Prognostic impact of C-reactive protein/albumin ratio on the overall survival of patients with advanced nonsmall cell lung cancers receiving palliative chemotherapy. Med (United States). 2017;96(19):e6848. doi:10.1097/MD.0000000000006848
5. Yamauchi Y, Safi S, Muley T, et al. C-reactive protein-albumin ratio is an independent prognostic predictor of tumor recurrence in stage IIIA-N2 lung adenocarcinoma patients. Lung Cancer. 2017;114:62-67. doi:10.1016/j.lungcan.2017.11.002
6. Kim MH, Ahn JY, Song JE, et al. The C-reactive protein/albumin ratio as an independent predictor of mortality in patients with severe sepsis or septic shock treated with early goal-directed therapy. PLoS One. 2015;10(7):e0132109. doi:10.1371/journal.pone.0132109
7. Park J, Chung K, Song J, et al. The C-reactive protein/albumin ratio as a predictor of mortality in critically ill patients. J Clin Med. 2018;7(10): 333. doi:10.3390/jcm7100333
8. Mart&iacute;n-S&aacute;nchez FJ, Del Toro E, Cardassay E, et al. Clinical presentation and outcome across age categories among patients with COVID-19 admitted to a Spanish Emergency Department. Eur Geriatr Med. 2020; 11(5):829-841. doi:10.1007/s41999-020-00359-2
9. Almazeedi S, Al-Youha S, Jamal MH, et al. Characteristics, risk factors and outcomes among the first consecutive 1096 patients diagnosed with COVID-19 in Kuwait. EClinicalMedicine. 2020;24:100448. doi:10.1016/j.eclinm.2020.100448
10. Novelli L, Raimondi F, Ghirardi A, et al. At the peak of COVID-19 age and disease severity but not comorbidities are predictors of mortality: COVID-19 burden in Bergamo, Italy. Panminerva Med. 2021;63(1):51-61. doi:10.23736/S0031-0808.20.04063-X
11. Henry BM, De Oliveira MHS, Benoit S, Plebani M, Lippi G. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis. Clin Chem Lab Med. 2020;58(7):1021-1028. doi:10.1515/cclm-2020-0369
12. Ghahramani S, Tabrizi R, Lankarani KB, et al. Laboratory features of severe vs. non-severe COVID-19 patients in Asian populations: a systematic review and meta-analysis. Eur J Med Res. 2020;25(1):30. doi: 10.1186/s40001-020-00432-3
13. Fairclough E, Cairns E, Hamilton J, Kelly C. Evaluation of a modified early warning system for acute medical admissions and comparison with C-reactive protein/albumin ratio as a predictor of patient outcome. Clin Med (London). 2009;9(1):30-33. doi:10.7861/clinmedicine.9-1-30
14. Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507-513. doi:10.1016/S0140-6736(20)30211-7
15. Liu F, Li L, Xu M, et al. Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19. J Clin Virol. 2020;127:104370. doi:10.1016/j.jcv.2020.104370
16. Ponti G, Maccaferri M, Ruini C, Tomasi A, Ozben T. Biomarkers associated with COVID-19 disease progression. Crit Rev Clin Lab Sci. 2020;57(6):389-399. doi:10.1080/10408363.2020.1770685
17. Wang G, Wu C, Zhang Q, et al. C-reactive protein level may predict the risk of COVID-19 aggravation. Open Forum Infect Dis. 2020;7:ofaa153. doi:10.1093/ofid/ofaa153
18. Poggiali E, Zaino D, Immovilli P, et al. Lactate dehydrogenase and C-reactive protein as predictors of respiratory failure in COVID-19 patients. Clin Chim Acta. 2020;509:135-138. doi:10.1016/j.cca.2020.06.012
19. Tan C, Huang Y, Shi F, et al. C-reactive protein correlates with computed tomographic findings and predicts severe COVID-19 early. J Med Virol. 2020;92(7):856-862. doi:10.1002/jmv.25871
20. Huang J, Cheng A, Kumar R, et al. Hypoalbuminemia predicts the outcome of COVID-19 independent of age and co-morbidity. J Med Virol. 2020;92(10):2152-2158. doi:10.1002/jmv.26003
21. Viana-Llamas MC, Arroyo-Espliguero R, Silva-Obreg&oacute;n JA, et al Hypoalbuminemia on admission in COVID-19 infection: an early predictor of mortality and adverse events. A retrospective observational study. Med Clin (Barc). 2021;156(9):428-436. doi:10.1016/j.medcli.2020. 12.018
22. Wang X, Xu Y, Huang H, et al. Increased pretreatment C-reactive protein-to-albumin ratio predicts severe coronavirus disease 2019. Research Square. 2020. doi:10.21203/rs.3.rs-31723/v2
23. Karakoyun I, Colak A, Turken M, et al. Diagnostic utility of C-reactive protein to albumin ratio as an early warning sign in hospitalized severe COVID-19 patients. Int Immunopharmacol. 2021;91:107285. doi:10. 1016/j.intimp.2020.107285
24. G&uuml;ney B&Ccedil;, Taştan Y&Ouml;, Doğantekin B, et al. Predictive value of CAR for in-hospital mortality in patients with COVID-19 pneumonia: a retrospective cohort study. Arch Med Res. 2021:52(5):554-560. doi:10. 1016/j.arcmed.2021.02.006
Article available in :
Volume 3, Issue 3, 2025
Page : 58-63
https://doi.org/10.51271/JOPIC-0060
Article Information
Received : 03 Tem 2025
Accepted : 12 Ağu 2025
Published : 20 Ağu 2025
Corresponding Author :

Kübra Günay: Department of Pulmonology, Gülhane Training and Research Hospital, Ankara, Turkiye

[email protected]
Citation : Günay K, Akçalı Duru S, Kurt EB, Arı M. The relationship between serum C-reactive protein to albumin ratio and the severity and prognosis of COVID-19. J Pulmonol Intens Care. 2025;3(3):58-63.

Read: 135
Download : 394
Cited: 0
_Footer